The results of the validation set and training + validation set revealed that the expression levels of BLACAT1 in CRC patients were higher than that in health controls (Fig. 5) but ZFAS1 had no significantly statistical difference (Supplementary Figure S3). This evidence concerns the gene ZFAS1 and colorectal carcinoma.